Free Oregon weighs plan to deny Medicaid payment for NGS as panel declares “no evidence of clinical utility” September 26, 2018By Matthew Bin Han Ong
FreeTrials & Tribulations Shrinking oncology phase I clinical trials: If the drug is a breakthrough, why would you ever want to utilize the maximally tolerated dose? September 21, 2018Vol.44 No.35By Mark J. Ratain
Senate passes conference bill, giving NIH $2 billion raise September 21, 2018Vol.44 No.35By Matthew Bin Han Ong
As José Baselga clears his desk, MSK forms task force on conflicts;meanwhile, new allegations emerge over center's role in AI start-up September 21, 2018Vol.44 No.35By Paul Goldberg
Free ASCO urges CMS to drop proposal that threatens to reduce access for Medicare cancer patients September 14, 2018Vol.44 No.34
Free A color-coded document Baselga created to explain himself instead illustrated the extent of his confusion and exposure September 14, 2018Vol.44 No.34By Paul Goldberg
Free José Baselga resigns as physician-in-chief at Memorial Sloan Kettering September 14, 2018Vol.44 No.34By Paul Goldberg and Matthew Bin Han Ong
Free José Baselga: “I take responsibility for failing to make appropriate disclosures” September 10, 2018By Matthew Bin Han Ong and Paul Goldberg
